Search

everythinglearnresearchcommunity

for

Search:↓

The paper concludes that detailed patient history, skin exams, and lab tests are crucial for diagnosing and treating hair loss from diffuse alopecia.

R-spondin2 may help treat hair loss, gene differences could explain baldness, a peptide's regulation is linked to psoriasis, B-defensin gene copies may affect a skin condition's risk and severity, and potential markers and targets for alopecia areata were identified.

Men with male pattern baldness may not have different hormone levels, but their hair follicles are likely more sensitive to hormones.

PPARgamma is crucial for healthy hair follicles, and its loss causes scarring alopecia.

Traditional Chinese medicine may effectively treat hair loss with fewer side effects.

Folliculitis decalvans mainly affects middle-aged African American men and is treated with antibiotics.

A substance called prostaglandin D2 is found more in bald scalps and it stops hair from growing. Blocking its receptor could potentially treat hair loss.

Hair loss treated with minoxidil, finasteride, laser/light, hair transplant, and scalp prostheses; more research needed for skin of color.

Prostaglandin D2, found in higher levels in bald scalps, stops hair growth, suggesting that blocking its receptor could potentially treat hair loss.

Folliculitis decalvans is a rare scalp condition causing scarring hair loss, treated with long-term antibiotics and other medications, but it often comes back and is hard to manage.

Prolactin contributes to hair loss by promoting hair follicle shrinkage and cell death.

Alopecia areata is caused by immune attacks on hair follicles, affecting hair growth and quality of life.

Genes linked to fibrosis are more active in people with central centrifugal cicatricial alopecia.

Alfredo Rebora suggested a new, easier way to classify hair loss in Telogen Effluvium, adding a type possibly related to autoimmune diseases.

Hidradenitis suppurativa is linked to autoinflammation and immune system issues.

Stress can trigger or worsen alopecia areata.

Serum biomarkers like insulin-like growth factor-1 and vitamin D may help diagnose androgenetic alopecia.

Cell adhesion molecules are important in the development of certain skin diseases.

These hair loss conditions might be part of a spectrum, not separate issues.

Hair loss due to scalp metastasis from breast cancer, known as Neoplastic Alopecia, has a better survival rate than other scalp metastases and requires a biopsy for diagnosis.

Hormonal imbalances in Polycystic Ovarian Syndrome (PCOS) might trigger a rare skin disorder called Confluent and Reticulated Papillomatosis (CRP), so dermatologists should consider checking for PCOS in CRP patients.

AD-derived keratinocytes effectively mimic inflammation in atopic dermatitis.

A woman's rare scalp condition worsened after using a specific arthritis medication, suggesting such medications can sometimes trigger or aggravate psoriasis.

Improving scalp microbiome may help restore hair and improve scalp health.

Scalp involvement in primary cutaneous lymphomas is common and can be aggressive, requiring careful attention.

The document is a detailed medical reference on skin and genetic disorders.

Diagnosing and treating rapidly worsening lung disease is difficult and requires better guidelines and understanding.

Pubertal acne is linked to hormonal changes, affects quality of life, and is treated similarly to adult acne.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Vitamin D is important for skin health and can affect various skin diseases.